StockData
Interpace Biosciences, Inc. logo

Interpace Biosciences, Inc. (IDXG) stock

IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)

Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –

Interpace Biosciences cash

Cash and short-term investments held at the end of each period.

Interpace Biosciences's cash was $2.69M at Jun 30, 2026. For fiscal 2025 it was $2.51M, up 71.5% from the year before. Over ten years it grew -11.4% a year on average. The highest annual figure on record is $72.46M in fiscal 2009.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.51M+71.5%
FY2024Dec 31, 2024$1.46M-58.2%
FY2023Dec 31, 2023$3.50M-27.5%
FY2022Dec 31, 2022$4.83M+45.7%
FY2021Dec 31, 2021$3.31M-1.7%
FY2020Dec 31, 2020$3.37M+45.3%
FY2019Dec 31, 2019$2.32M-61.8%
FY2018Dec 31, 2018$6.07M-60.1%
FY2017Dec 31, 2017$15.20M+2424.8%
FY2016Dec 31, 2016$602.00K-92.8%
FY2015Dec 31, 2015$8.42M-63.8%
FY2014Dec 31, 2014$23.22M-49.2%
FY2013Dec 31, 2013$45.74M-13.5%
FY2012Dec 31, 2012$52.88M-18.0%
FY2011Dec 31, 2011$64.46M+2.6%
FY2010Dec 31, 2010$62.86M-13.3%
FY2009Dec 31, 2009$72.46M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.69M+435.5%
Q1 FY2026Mar 31, 2026$2.65M+121.3%
Q4 FY2025Dec 31, 2025$2.51M+71.5%
Q3 FY2025Sep 30, 2025$1.42M+1.6%
Q2 FY2025Jun 30, 2025$502.00K+0.4%
Q1 FY2025Mar 31, 2025$1.20M-57.5%
Q4 FY2024Dec 31, 2024$1.46M-58.2%
Q3 FY2024Sep 30, 2024$1.40M-72.2%
Q2 FY2024Jun 30, 2024$500.00K-90.2%
Q1 FY2024Mar 31, 2024$2.81M-49.7%
Q4 FY2023Dec 31, 2023$3.50M-27.5%
Q3 FY2023Sep 30, 2023$5.03M-20.2%
Q2 FY2023Jun 30, 2023$5.08M+140.1%
Q1 FY2023Mar 31, 2023$5.60M+80.5%
Q4 FY2022Dec 31, 2022$4.83M+45.7%
Q3 FY2022Sep 30, 2022$6.31M+83.9%
Q2 FY2022Jun 30, 2022$2.12M-44.2%
Q1 FY2022Mar 31, 2022$3.10M+9.2%
Q4 FY2021Dec 31, 2021$3.31M-1.7%
Q3 FY2021Sep 30, 2021$3.43M-35.4%
Q2 FY2021Jun 30, 2021$3.79M-74.9%
Q1 FY2021Mar 31, 2021$2.84M-78.8%
Q4 FY2020Dec 31, 2020$3.37M+45.3%
Q3 FY2020Sep 30, 2020$5.31M+125.1%
Q2 FY2020Jun 30, 2020$15.11M+258.8%
Q1 FY2020Mar 31, 2020$13.37M+46.5%
Q4 FY2019Dec 31, 2019$2.32M-61.8%
Q3 FY2019Sep 30, 2019$2.36M-70.5%
Q2 FY2019Jun 30, 2019$4.21M-58.3%
Q1 FY2019Mar 31, 2019$9.12M-27.8%
Q4 FY2018Dec 31, 2018$6.07M-60.1%
Q3 FY2018Sep 30, 2018$8.00M-31.6%
Q2 FY2018Jun 30, 2018$10.08M-29.3%
Q1 FY2018Mar 31, 2018$12.65M+77.4%
Q4 FY2017Dec 31, 2017$15.20M+2424.8%
Q3 FY2017Sep 30, 2017$11.70M+591.3%
Q2 FY2017Jun 30, 2017$14.27M–
Q1 FY2017Mar 31, 2017$7.13M–
Q4 FY2016Dec 31, 2016$602.00K–
Q3 FY2016Sep 30, 2016$1.69M–

More Interpace Biosciences figures

See a number that looks wrong?